SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
SEC Accession No. 0001571049-16-011809
Filing Date
2016-02-16
Accepted
2016-02-16 13:25:51
Documents
2
Group Members
ALFRED SCHEIDEGGERMARCO WEIBELNEXTECH III GP LTD.THOMAS LIPS

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 13G (AMENDMENT NO. 1) t1600072_sc13ga.htm SC 13G/A 101843
2 EXHIBIT 99.1 t1600072_99-1.htm EX-99.1 6922
  Complete submission text file 0001571049-16-011809.txt   110512
Mailing Address 8910 UNIVERSITY CENTER DRIVE SUITE 700 San Diego CA 92122
Business Address 8910 UNIVERSITY CENTER DRIVE SUITE 700 San Diego CA 92122 858-550-0780
Tracon Pharmaceuticals, Inc. (Subject) CIK: 0001394319 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-88629 | Film No.: 161425968
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address SCHEUCHZERSTRASSE 35 ZURICH V8 8006
Business Address SCHEUCHZERSTRASSE 35 ZURICH V8 8006 410443666612
Nextech III Oncology, LPCI (Filed by) CIK: 0001595470 (see all company filings)

IRS No.: 000000000 | State of Incorp.: V8 | Fiscal Year End: 1231
Type: SC 13G/A